Pilgrim’s Document Management solution will replace a paper-based system to better manage Megadyne’s increasing volume of documentation and related change controls by enabling the company to effectively create,
ICT-107 is the company’s dendritic cell based cancer vaccine candidate for the treatment of glioblastoma multiforme (GBM). The study will enroll approximately 100 patients, and will be conducted
The court found Actavis and co-defendant Actavis Elizabeth to have misrepresented its drug prices to Medicaid. The decision came after Florida-based pharmacy Ven-a-Care filed a whistleblower lawsuit under
The web-based PILOT MES/WDS production management system from FELTEN is expected to increase Lonza’s fermentation capacities by 50%. Lonza’s investment in the new multi-product manufacturing facility was necessary
Optimer said fidaxomicin is the first in a new class of antibiotics called macrocycles, which inhibit the bacterial enzyme RNA polymerase, resulting in the rapid killing of C
Merck will examine magentic beads coated with CardioGenics’ silver-coating and polymer encapsulation processes while refining encapsulation of the beads. The silver-coating technology of the CardioGenics enhances the signaling
For the fourth quarter of 2010, the company posted a net income of $236m, or $0.15 per diluted share, compared to a net loss of $1.07bn, or $0.71
The company also reported that the first patient within the trial has been successfully genotyped and treatment has been initiated. LGC is collaborating with researchers from six European
Immunocytokine hu14.18-IL2 – an investigational antibody-based biologic, met drug development endpoints in a Phase II study involving certain paediatric neuroblastoma subjects, following which it has progressed to a
The formula is the latest addition to the Nestle Peptamen product family. Nestle HealthCare Nutrition has developed it with a unique protein-to-calorie ratio to help meet the protein
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.